Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Neurosurg Rev. 2023 Aug 29;46(1):214. doi: 10.1007/s10143-023-02122-0.
In aqueduct stenosis, pressure difference below and above level of obstruction leads to bulging of third ventricular floor (TVF) and lamina terminalis (LT). Endoscopic third ventriculocisternostomy (ETV) is the standard treatment in these patients. We tried to assess success of ETV depending on those two radiological changes in aqueduct stenosis. We implemented "Heidelberg ETV score" retrospectively to assess the state of TVF as well as LT in same manner in midsagittal MR image. Every patient had a preoperative, direct, 3-months and one-year postoperative score from -2 to + 2. We correlated the scores to clinical course to decide whether the score is reliable in defining success of ETV. Between 2017-2021, 67 (mean age 25.6 ± 23.9y) patients treated with ETV were included. Success rate of primary and Re-ETVs was 91% over 46.8 ± 19.0 months. A marked shift of score to the left after surgery in success group was noticed through the distribution of score immediate postoperative, 3-months later; 70.2% showed (+ 2) before surgery, 38.9% scored (0) after surgery and 50.9% showed further score drop to (-1) 3 months later, p < 0.001. In cases of failure, there was initial decrease after surgery followed by increase with ETV-failure (mean time to failure: 7.2 ± 5.7 months) in 100%. Significant difference was noticed in Heidelberg score at postoperative 1-year- and failure-MRI follow-up between two groups, p < 0.001. Heidelberg score describes anatomical changes in third ventricle after ETV and can serve in assessment of MR images to define success of the procedure in patients with aqueduct stenosis.
在导水管狭窄中,阻塞下方和上方的压力差导致第三脑室底(TVF)和终板隆起。内镜第三脑室底造瘘术(ETV)是这些患者的标准治疗方法。我们试图根据导水管狭窄的这两种影像学变化来评估 ETV 的成功率。我们回顾性地实施了“海德堡 ETV 评分”,以同样的方式在正中矢状位 MRI 图像上评估 TVF 和终板的状态。每位患者均有术前、直接、术后 3 个月和 1 年的评分,范围从-2 到+2。我们将这些评分与临床病程相关联,以确定该评分是否可靠地定义 ETV 的成功。2017-2021 年间,我们纳入了 67 例(平均年龄 25.6±23.9 岁)接受 ETV 治疗的患者。原发性和再 ETV 的成功率为 91%,随访时间为 46.8±19.0 个月。在成功组中,手术后评分明显向左转移,通过术后即刻、3 个月后的评分分布可以看出;术前 70.2%为(+2),术后 38.9%为(0),50.9%在术后 3 个月进一步下降至(-1),p<0.001。在失败病例中,手术后有初始下降,随后随着 ETV 失败而增加(平均失败时间:7.2±5.7 个月),100%的患者均出现这种情况。两组在术后 1 年和失败 MRI 随访时的海德堡评分有显著差异,p<0.001。海德堡评分描述了 ETV 后第三脑室的解剖学变化,可用于评估 MRI 图像,以确定导水管狭窄患者手术的成功率。